{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:39:57Z","timestamp":1790375997657,"version":"4.1.0"},"reference-count":243,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2018,6,4]],"date-time":"2018-06-04T00:00:00Z","timestamp":1528070400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"DOI":"10.3389\/fonc.2018.00198","type":"journal-article","created":{"date-parts":[[2018,6,4]],"date-time":"2018-06-04T00:28:48Z","timestamp":1528072128000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":64,"title":["New Therapies and Immunological Findings in Cutaneous T-Cell Lymphoma"],"prefix":"10.3389","volume":"8","author":[{"given":"Kazuyasu","family":"Fujii","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2018,6,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1093\/jnci\/92.15.1240","article-title":"Cancer surveillance series: non-Hodgkin\u2019s lymphoma incidence by histologic subtype in the United States from 1978 through 1995","volume":"92","author":"Groves","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"B2","doi-asserted-by":"publisher","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"B3","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1001\/archderm.143.7.854","article-title":"Incidence of cutaneous T-cell lymphoma in the United States, 1973-2002","volume":"143","author":"Criscione","year":"2007","journal-title":"Arch Dermatol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1111\/j.1610-0387.2007.06337.x","article-title":"Cutaneous lymphomas in Germany: an analysis of the central cutaneous lymphoma registry of the German society of dermatology (DDG)","volume":"5","author":"Assaf","year":"2007","journal-title":"J Dtsch Dermatol Ges"},{"key":"B5","doi-asserted-by":"publisher","first-page":"5064","DOI":"10.1182\/blood-2008-10-184168","article-title":"Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases","volume":"113","author":"Bradford","year":"2009","journal-title":"Blood"},{"key":"B6","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/1346-8138.12299","article-title":"Cutaneous lymphoma in Japan: a nationwide study of 1733 patients","volume":"41","author":"Hamada","year":"2014","journal-title":"J Dermatol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1001\/jama.1988.03410010050033","article-title":"Mycosis fungoides in the United States. Increasing incidence and descriptive epidemiology","volume":"260","author":"Weinstock","year":"1988","journal-title":"JAMA"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1038\/jid.2010.58","article-title":"Incidence and trends of cutaneous malignancies in the Netherlands, 1989-2005","volume":"130","author":"Holterhues","year":"2010","journal-title":"J Invest Dermatol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"368","DOI":"10.5114\/pdia.2015.54749","article-title":"Primary cutaneous lymphomas: diagnosis and treatment","volume":"32","author":"Sokolowska-Wojdylo","year":"2015","journal-title":"Postepy Dermatol Alergol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2375","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow","year":"2016","journal-title":"Blood"},{"key":"B11","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1590\/abd1806-4841.20176825","article-title":"Primary cutaneous T-cell lymphoma: experience from the Peruvian National Cancer Institute","volume":"92","author":"Ruiz","year":"2017","journal-title":"An Bras Dermatol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1182\/blood-2007-03-055749","article-title":"Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC)","volume":"110","author":"Olsen","year":"2007","journal-title":"Blood"},{"key":"B13","doi-asserted-by":"publisher","first-page":"4730","DOI":"10.1200\/JCO.2009.27.7665","article-title":"Survival outcomes and prognostic factors in mycosis fungoides\/Sezary syndrome: validation of the revised International Society for Cutaneous Lymphomas\/European Organisation for Research and treatment of cancer staging proposal","volume":"28","author":"Agar","year":"2010","journal-title":"J Clin Oncol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1182\/blood-2011-08-376319","article-title":"Prognostic factors in transformed mycosis fungoides: a retrospective analysis of 100 cases","volume":"119","author":"Benner","year":"2012","journal-title":"Blood"},{"key":"B15","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1182\/blood-2009-11-251926","article-title":"Sezary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors","volume":"116","author":"Campbell","year":"2010","journal-title":"Blood"},{"key":"B16","doi-asserted-by":"publisher","first-page":"1388","DOI":"10.1182\/blood.V97.5.1388","article-title":"CD4(+) cutaneous T-cell lymphoma cells express the p140-killer cell immunoglobulin-like receptor","volume":"97","author":"Bagot","year":"2001","journal-title":"Blood"},{"key":"B17","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1111\/j.0022-202X.2004.22326.x","article-title":"CD158k\/KIR3DL2 is a new phenotypic marker of Sezary cells: relevance for the diagnosis and follow-up of Sezary syndrome","volume":"122","author":"Poszepczynska-Guigne","year":"2004","journal-title":"J Invest Dermatol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1002\/path.1251","article-title":"Killer cell immunoglobulin-like receptor expression delineates in situ Sezary syndrome lymphocytes","volume":"199","author":"Wechsler","year":"2003","journal-title":"J Pathol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1182\/blood-2008-04-153031","article-title":"Oncogenomic analysis of mycosis fungoides reveals major differences with Sezary syndrome","volume":"113","author":"van Doorn","year":"2009","journal-title":"Blood"},{"key":"B20","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1038\/jid.2010.8","article-title":"Genome-wide analysis of cutaneous T-cell lymphomas identifies three clinically relevant classes","volume":"130","author":"Laharanne","year":"2010","journal-title":"J Invest Dermatol"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1038\/ng.3444","article-title":"Genomic profiling of Sezary syndrome identifies alterations of key T cell signaling and differentiation genes","volume":"47","author":"Wang","year":"2015","journal-title":"Nat Genet"},{"key":"B22","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.1038\/jid.2011.27","article-title":"Malignant cutaneous T-cell lymphoma cells express IL-17 utilizing the Jak3\/Stat3 signaling pathway","volume":"131","author":"Krejsgaard","year":"2011","journal-title":"J Invest Dermatol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"1640","DOI":"10.1182\/blood-2004-06-2181","article-title":"Cutaneous T-cell lymphoma: malignant proliferation of T-regulatory cells","volume":"105","author":"Berger","year":"2005","journal-title":"Blood"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1038\/jid.2009.175","article-title":"FOXP3+CD25\u2212 tumor cells with regulatory function in Sezary syndrome","volume":"129","author":"Heid","year":"2009","journal-title":"J Invest Dermatol"},{"key":"B25","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.jdermsci.2010.05.005","article-title":"Chemokines and cutaneous lymphoma","volume":"59","author":"Sugaya","year":"2010","journal-title":"J Dermatol Sci"},{"key":"B26","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1309\/3N7P-J84L-JQ9K-G89R","article-title":"The T-cell chemokine receptor CXCR3 is expressed highly in low-grade mycosis fungoides","volume":"115","author":"Lu","year":"2001","journal-title":"Am J Clin Pathol"},{"key":"B27","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1182\/blood.V86.2.651.bloodjournal862651","article-title":"Cytokine loops involving interferon-gamma and IP-10, a cytokine chemotactic for CD4+ lymphocytes: an explanation for the epidermotropism of cutaneous T-cell lymphoma?","volume":"86","author":"Sarris","year":"1995","journal-title":"Blood"},{"key":"B28","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1046\/j.1523-1747.1998.00263.x","article-title":"Epidermal interferon-gamma inducible protein-10 (IP-10) and monokine induced by gamma-interferon (Mig) but not IL-8 mRNA expression is associated with epidermotropism in cutaneous T cell lymphomas","volume":"111","author":"Tensen","year":"1998","journal-title":"J Invest Dermatol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1280","DOI":"10.1038\/jid.2011.470","article-title":"Low herpesvirus entry mediator (HVEM) expression on dermal fibroblasts contributes to a Th2-dominant microenvironment in advanced cutaneous T-cell lymphoma","volume":"132","author":"Miyagaki","year":"2012","journal-title":"J Invest Dermatol"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1405","DOI":"10.1046\/j.1523-1747.2002.19610.x","article-title":"Increased CCR4 expression in cutaneous T cell lymphoma","volume":"119","author":"Ferenczi","year":"2002","journal-title":"J Invest Dermatol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1111\/1346-8138.12305","article-title":"Immunological milieu in mycosis fungoides and Sezary syndrome","volume":"41","author":"Miyagaki","year":"2014","journal-title":"J Dermatol"},{"key":"B32","doi-asserted-by":"publisher","first-page":"7529","DOI":"10.1158\/1078-0432.CCR-11-1192","article-title":"IL-22, but not IL-17, dominant environment in cutaneous T-cell lymphoma","volume":"17","author":"Miyagaki","year":"2011","journal-title":"Clin Cancer Res"},{"key":"B33","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1046\/j.1523-1747.2003.12555.x","article-title":"Chemokine receptor expression on neoplastic and reactive T cells in the skin at different stages of mycosis fungoides","volume":"121","author":"Kallinich","year":"2003","journal-title":"J Invest Dermatol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1038\/jid.2009.45","article-title":"Cutaneous T-cell lymphoma: roles for chemokines and chemokine receptors","volume":"129","author":"Wu","year":"2009","journal-title":"J Invest Dermatol"},{"key":"B35","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1111\/j.1365-2133.2004.06325.x","article-title":"Circulating clonal CLA(+) and CD4(+) T cells in Sezary syndrome express the skin-homing chemokine receptors CCR4 and CCR10 as well as the lymph node-homing chemokine receptor CCR7","volume":"152","author":"Sokolowska-Wojdylo","year":"2005","journal-title":"Br J Dermatol"},{"key":"B36","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1182\/blood-2005-04-1492","article-title":"Skin homing of Sezary cells involves SDF-1-CXCR4 signaling and down-regulation of CD26\/dipeptidylpeptidase IV","volume":"107","author":"Narducci","year":"2006","journal-title":"Blood"},{"key":"B37","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1067\/mjd.2003.132","article-title":"Thymus and activation-regulated chemokine (TARC\/CCL17) in mycosis fungoides: serum TARC levels reflect the disease activity of mycosis fungoides","volume":"48","author":"Kakinuma","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"B38","doi-asserted-by":"publisher","first-page":"14470","DOI":"10.1073\/pnas.96.25.14470","article-title":"CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells","volume":"96","author":"Morales","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1158\/1078-0432.CCR-05-1513","article-title":"Presence of circulating CCR10+ T cells and elevated serum CTACK\/CCL27 in the early stage of mycosis fungoides","volume":"12","author":"Fujita","year":"2006","journal-title":"Clin Cancer Res"},{"key":"B40","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1111\/j.1365-2133.2012.10818.x","article-title":"Serum and tissue CTACK\/CCL27 chemokine levels in early mycosis fungoides may be correlated with disease-free survival following treatment with interferon alfa and psoralen plus ultraviolet A therapy","volume":"166","author":"Goteri","year":"2012","journal-title":"Br J Dermatol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"437","DOI":"10.5114\/pdia.2015.48034","article-title":"Expression of CXCR4 and CXCL12 and their correlations to the cell proliferation and angiogenesis in mycosis fungoides","volume":"32","author":"Maj","year":"2015","journal-title":"Postepy Dermatol Alergol"},{"key":"B42","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1111\/1523-1747.ep12611877","article-title":"Aberrant cytokine production by Sezary syndrome patients: cytokine secretion pattern resembles murine Th2 cells","volume":"99","author":"Vowels","year":"1992","journal-title":"J Invest Dermatol"},{"key":"B43","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1001\/archderm.1993.01680250045005","article-title":"Peripheral blood mononuclear cells in patients with nonleukemic cutaneous T-cell lymphoma. Reduced proliferation and preferential secretion of a T helper-2-like cytokine pattern on stimulation","volume":"129","author":"Dummer","year":"1993","journal-title":"Arch Dermatol"},{"key":"B44","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1111\/1523-1747.ep12398454","article-title":"Th2 cytokine mRNA expression in skin in cutaneous T-cell lymphoma","volume":"103","author":"Vowels","year":"1994","journal-title":"J Invest Dermatol"},{"key":"B45","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1182\/blood.V88.4.1383.bloodjournal8841383","article-title":"Sezary syndrome T-cell clones display T-helper 2 cytokines and express the accessory factor-1 (interferon-gamma receptor beta-chain)","volume":"88","author":"Dummer","year":"1996","journal-title":"Blood"},{"key":"B46","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1182\/blood.V88.2.757.bloodjournal882757","article-title":"Interferon gamma and tumor necrosis factor alpha mRNA expression in mycosis fungoides progression","volume":"88","author":"Asadullah","year":"1996","journal-title":"Blood"},{"key":"B47","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1111\/1523-1747.ep12330869","article-title":"Progression of mycosis fungoides is associated with increasing cutaneous expression of interleukin-10 mRNA","volume":"107","author":"Asadullah","year":"1996","journal-title":"J Invest Dermatol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"3755","DOI":"10.1158\/1078-0432.CCR-12-3488","article-title":"TH2 cytokines from malignant cells suppress TH1 responses and enforce a global TH2 bias in leukemic cutaneous T-cell lymphoma","volume":"19","author":"Guenova","year":"2013","journal-title":"Clin Cancer Res"},{"key":"B49","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1093\/jnci\/82.3.208","article-title":"Phase II study of recombinant human interferon gamma for treatment of cutaneous T-cell lymphoma","volume":"82","author":"Kaplan","year":"1990","journal-title":"J Natl Cancer Inst"},{"key":"B50","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/1346-8138.12341","article-title":"Phase II study of i.v. interferon-gamma in Japanese patients with mycosis fungoides","volume":"41","author":"Sugaya","year":"2014","journal-title":"J Dermatol"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1631","DOI":"10.1182\/blood-2004-01-0360","article-title":"Adenovirus-mediated intralesional interferon-gamma gene transfer induces tumor regressions in cutaneous lymphomas","volume":"104","author":"Dummer","year":"2004","journal-title":"Blood"},{"key":"B52","doi-asserted-by":"publisher","first-page":"2834","DOI":"10.1172\/JCI32077","article-title":"Type I IFN innate immune response to adenovirus-mediated IFN-gamma gene transfer contributes to the regression of cutaneous lymphomas","volume":"117","author":"Urosevic","year":"2007","journal-title":"J Clin Invest"},{"key":"B53","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1038\/mt.2010.52","article-title":"Phase II clinical trial of intratumoral application of TG1042 (adenovirus-interferon-gamma) in patients with advanced cutaneous T-cell lymphomas and multilesional cutaneous B-cell lymphomas","volume":"18","author":"Dummer","year":"2010","journal-title":"Mol Ther"},{"key":"B54","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1111\/j.1365-2133.2003.05674.x","article-title":"Interaction of cutaneous lymphoma cells with reactive T cells and dendritic cells: implications for dendritic cell-based immunotherapy","volume":"149","author":"Thumann","year":"2003","journal-title":"Br J Dermatol"},{"key":"B55","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/j.1365-2133.2008.08612.x","article-title":"Prevalence and treatment of Staphylococcus aureus colonization in patients with mycosis fungoides and Sezary syndrome","volume":"159","author":"Talpur","year":"2008","journal-title":"Br J Dermatol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1177\/107327480100800213","article-title":"Infectious complications of cutaneous t-cell lymphoma","volume":"8","author":"Tsambiras","year":"2001","journal-title":"Cancer Control"},{"key":"B57","doi-asserted-by":"publisher","first-page":"5051","DOI":"10.1158\/1078-0432.CCR-12-0604","article-title":"Long-term outcomes of 1,263 patients with mycosis fungoides and Sezary syndrome from 1982 to 2009","volume":"18","author":"Talpur","year":"2012","journal-title":"Clin Cancer Res"},{"key":"B58","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.4049\/jimmunol.163.7.4073","article-title":"Depressed IL-12-mediated signal transduction in T cells from patients with Sezary syndrome is associated with the absence of IL-12 receptor beta 2 mRNA and highly reduced levels of STAT4","volume":"163","author":"Showe","year":"1999","journal-title":"J Immunol"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1939","DOI":"10.4161\/cc.24987","article-title":"STAT5-mediated expression of oncogenic miR-155 in cutaneous T-cell lymphoma","volume":"12","author":"Kopp","year":"2013","journal-title":"Cell Cycle"},{"key":"B60","doi-asserted-by":"publisher","first-page":"3331","DOI":"10.4161\/15384101.2014.965061","article-title":"Deregulation in STAT signaling is important for cutaneous T-cell lymphoma (CTCL) pathogenesis and cancer progression","volume":"13","author":"Netchiporouk","year":"2014","journal-title":"Cell Cycle"},{"key":"B61","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/j.1749-6632.1996.tb52680.x","article-title":"The potential therapeutic role of interleukin-12 in cutaneous T-cell lymphoma","volume":"795","author":"Rook","year":"1996","journal-title":"Ann N Y Acad Sci"},{"key":"B62","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/jid.2011.293","article-title":"Autocrine IL-21 stimulation is involved in the maintenance of constitutive STAT3 activation in Sezary syndrome","volume":"132","author":"van der Fits","year":"2012","journal-title":"J Invest Dermatol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1046\/j.0022-202x.2001.01436.x","article-title":"Constitutive and interleukin-7- and interleukin-15-stimulated DNA binding of STAT and novel factors in cutaneous T cell lymphoma cells","volume":"117","author":"Qin","year":"2001","journal-title":"J Invest Dermatol"},{"key":"B64","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1038\/sj.leu.2401415","article-title":"Inhibition of constitutively activated Stat3 correlates with altered Bcl-2\/Bax expression and induction of apoptosis in mycosis fungoides tumor cells","volume":"13","author":"Nielsen","year":"1999","journal-title":"Leukemia"},{"key":"B65","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1038\/sj.jid.5701246","article-title":"Cucurbitacin I inhibits Stat3 and induces apoptosis in Sezary cells","volume":"128","author":"van Kester","year":"2008","journal-title":"J Invest Dermatol"},{"key":"B66","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/jid.2012.265","article-title":"Impaired proteasome function activates GATA3 in T cells and upregulates CTLA-4: relevance for Sezary syndrome","volume":"133","author":"Gibson","year":"2013","journal-title":"J Invest Dermatol"},{"key":"B67","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/35077241","article-title":"The microenvironment of the tumour-host interface","volume":"411","author":"Liotta","year":"2001","journal-title":"Nature"},{"key":"B68","doi-asserted-by":"publisher","first-page":"2304","DOI":"10.1038\/jid.2010.128","article-title":"Eotaxins and CCR3 interaction regulates the Th2 environment of cutaneous T-cell lymphoma","volume":"130","author":"Miyagaki","year":"2010","journal-title":"J Invest Dermatol"},{"key":"B69","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1182\/blood-2002-02-0475","article-title":"Functional expression of the eotaxin receptor CCR3 in CD30+ cutaneous T-cell lymphoma","volume":"101","author":"Kleinhans","year":"2003","journal-title":"Blood"},{"key":"B70","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1126\/science.277.5334.2005","article-title":"Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells","volume":"277","author":"Sallusto","year":"1997","journal-title":"Science"},{"key":"B71","doi-asserted-by":"publisher","first-page":"2171","DOI":"10.1084\/jem.185.12.2171","article-title":"Eotaxin-2, a novel CC chemokine that is selective for the chemokine receptor CCR3, and acts like eotaxin on human eosinophil and basophil leukocytes","volume":"185","author":"Forssmann","year":"1997","journal-title":"J Exp Med"},{"key":"B72","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1016\/j.ajpath.2013.11.012","article-title":"The niche component periostin is produced by cancer-associated fibroblasts, supporting growth of gastric cancer through ERK activation","volume":"184","author":"Kikuchi","year":"2014","journal-title":"Am J Pathol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1111\/exd.12873","article-title":"The possible interaction between periostin expressed by cancer stroma and tumor-associated macrophages in developing mycosis fungoides","volume":"25","author":"Furudate","year":"2016","journal-title":"Exp Dermatol"},{"key":"B74","doi-asserted-by":"publisher","first-page":"6241","DOI":"10.1158\/0008-5472.CAN-16-0992","article-title":"Thymic stromal chemokine TSLP Acts through Th2 cytokine production to induce cutaneous T-cell lymphoma","volume":"76","author":"Takahashi","year":"2016","journal-title":"Cancer Res"},{"key":"B75","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/ni805","article-title":"Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP","volume":"3","author":"Soumelis","year":"2002","journal-title":"Nat Immunol"},{"key":"B76","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/j.1365-2230.2008.02990.x","article-title":"Increased serum thymic stromal lymphopoietin levels in patients with cutaneous T cell lymphoma","volume":"34","author":"Miyagaki","year":"2009","journal-title":"Clin Exp Dermatol"},{"key":"B77","doi-asserted-by":"publisher","first-page":"440","DOI":"10.3109\/10428194.2014.919634","article-title":"CCR4+T cell recruitment to the skin in mycosis fungoides: potential contributions by thymic stromal lymphopoietin and interleukin-16","volume":"56","author":"Tuzova","year":"2015","journal-title":"Leuk Lymphoma"},{"key":"B78","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/0167-5699(92)90008-U","article-title":"The origin and function of tumor-associated macrophages","volume":"13","author":"Mantovani","year":"1992","journal-title":"Immunol Today"},{"key":"B79","doi-asserted-by":"publisher","first-page":"948098","DOI":"10.1155\/2012\/948098","article-title":"Macrophages in tumor microenvironments and the progression of tumors","volume":"2012","author":"Hao","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"B80","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/path.1027","article-title":"The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies","volume":"196","author":"Bingle","year":"2002","journal-title":"J Pathol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.jdermsci.2012.07.007","article-title":"Association of the numbers of CD163(+) cells in lesional skin and serum levels of soluble CD163 with disease progression of cutaneous T cell lymphoma","volume":"68","author":"Sugaya","year":"2012","journal-title":"J Dermatol Sci"},{"key":"B82","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/exd.12894","article-title":"Mac attack: macrophages as key drivers of cutaneous T-cell lymphoma pathogenesis","volume":"25","author":"Assaf","year":"2016","journal-title":"Exp Dermatol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1684\/ejd.2014.2437","article-title":"Increase of DC-LAMP+ mature dendritic cell subsets in dermatopathic lymphadenitis of mycosis fungoides","volume":"24","author":"Tada","year":"2014","journal-title":"Eur J Dermatol"},{"key":"B84","doi-asserted-by":"publisher","first-page":"2814","DOI":"10.1038\/jid.2014.206","article-title":"Depletion of M2-like tumor-associated macrophages delays cutaneous T-cell lymphoma development in vivo","volume":"134","author":"Wu","year":"2014","journal-title":"J Invest Dermatol"},{"key":"B85","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.4049\/jimmunol.160.3.1411","article-title":"Alternative macrophage activation-associated CC-chemokine-1, a novel structural homologue of macrophage inflammatory protein-1 alpha with a Th2-associated expression pattern","volume":"160","author":"Kodelja","year":"1998","journal-title":"J Immunol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1084\/jem.20130240","article-title":"Identification of human CCR8 as a CCL18 receptor","volume":"210","author":"Islam","year":"2013","journal-title":"J Exp Med"},{"key":"B87","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1016\/j.ajpath.2011.05.040","article-title":"Up-regulation of the chemokine CCL18 by macrophages is a potential immunomodulatory pathway in cutaneous T-cell lymphoma","volume":"179","author":"Gunther","year":"2011","journal-title":"Am J Pathol"},{"key":"B88","doi-asserted-by":"publisher","first-page":"e60","DOI":"10.1111\/j.1468-3083.2012.04495.x","article-title":"Increased CCL18 expression in patients with cutaneous T-cell lymphoma: association with disease severity and prognosis","volume":"27","author":"Miyagaki","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"3750","DOI":"10.1200\/JCO.2014.60.3969","article-title":"Phase II investigator-initiated study of brentuximab vedotin in mycosis fungoides and Sezary syndrome with variable CD30 expression level: a multi-institution collaborative project","volume":"33","author":"Kim","year":"2015","journal-title":"J Clin Oncol"},{"key":"B90","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/32588","article-title":"Dendritic cells and the control of immunity","volume":"392","author":"Banchereau","year":"1998","journal-title":"Nature"},{"key":"B91","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1046\/j.1365-2133.2002.04994.x","article-title":"Dendritic cells and apoptosis in mycosis fungoides","volume":"147","author":"Luftl","year":"2002","journal-title":"Br J Dermatol"},{"key":"B92","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.jaad.2009.06.082","article-title":"High numbers of DC-SIGN+ dendritic cells in lesional skin of cutaneous T-cell lymphoma","volume":"62","author":"Schlapbach","year":"2010","journal-title":"J Am Acad Dermatol"},{"key":"B93","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.jdermsci.2008.08.011","article-title":"Quantitative analysis of nerve growth factor (NGF) in the atopic dermatitis and psoriasis horny layer and effect of treatment on NGF in atopic dermatitis","volume":"53","author":"Yamaguchi","year":"2009","journal-title":"J Dermatol Sci"},{"key":"B94","doi-asserted-by":"publisher","first-page":"144","DOI":"10.2340\/00015555-1428","article-title":"Association of nerve growth factor, chemokine (C-C motif) ligands and immunoglobulin E with pruritus in cutaneous T-cell lymphoma","volume":"93","author":"Suga","year":"2013","journal-title":"Acta Derm Venereol"},{"key":"B95","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1007\/978-1-4419-9533-9_14","article-title":"Mast cells, angiogenesis and cancer","volume":"716","author":"Ribatti","year":"2011","journal-title":"Adv Exp Med Biol"},{"key":"B96","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1182\/blood-2012-03-415638","article-title":"Mast cells play a protumorigenic role in primary cutaneous lymphoma","volume":"120","author":"Rabenhorst","year":"2012","journal-title":"Blood"},{"key":"B97","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/nm1720","article-title":"Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens","volume":"14","author":"Zheng","year":"2008","journal-title":"Nat Med"},{"key":"B98","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1111\/bjd.12051","article-title":"CD8+ Sezary syndrome with interleukin-22 production modulated by bacterial sepsis","volume":"168","author":"Shimauchi","year":"2013","journal-title":"Br J Dermatol"},{"key":"B99","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/nri2506","article-title":"Myeloid-derived suppressor cells as regulators of the immune system","volume":"9","author":"Gabrilovich","year":"2009","journal-title":"Nat Rev Immunol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s00428-017-2107-1","article-title":"Langerhans, plasmacytoid dendritic and myeloid-derived suppressor cell levels in mycosis fungoides vary according to the stage of the disease","volume":"470","author":"Pileri","year":"2017","journal-title":"Virchows Arch"},{"key":"B101","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1001\/archdermatol.2010.200","article-title":"Increased programmed death-1 expression on CD4+ T cells in cutaneous T-cell lymphoma: implications for immune suppression","volume":"146","author":"Samimi","year":"2010","journal-title":"Arch Dermatol"},{"key":"B102","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1097\/DAD.0b013e31821c35cb","article-title":"Expression patterns of the immunosuppressive proteins PD-1\/CD279 and PD-L1\/CD274 at different stages of cutaneous T-cell lymphoma\/mycosis fungoides","volume":"34","author":"Kantekure","year":"2012","journal-title":"Am J Dermatopathol"},{"key":"B103","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/sj.jid.5700029","article-title":"Increased expression of CTLA-4 in malignant T-cells from patients with mycosis fungoides \u2013 cutaneous T cell lymphoma","volume":"126","author":"Wong","year":"2006","journal-title":"J Invest Dermatol"},{"key":"B104","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1097\/DAD.0000000000000258","article-title":"Expression of T-follicular helper markers in sequential biopsies of progressive mycosis fungoides and other primary cutaneous T-cell lymphomas","volume":"37","author":"Bosisio","year":"2015","journal-title":"Am J Dermatopathol"},{"key":"B105","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1002\/ajh.24876","article-title":"Cutaneous T-cell lymphoma: 2017 update on diagnosis, risk-stratification, and management","volume":"92","author":"Wilcox","year":"2017","journal-title":"Am J Hematol"},{"key":"B106","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1182\/blood-2014-07-588236","article-title":"Lack of durable disease control with chemotherapy for mycosis fungoides and Sezary syndrome: a comparative study of systemic therapy","volume":"125","author":"Hughes","year":"2015","journal-title":"Blood"},{"key":"B107","first-page":"1","article-title":"Therapeutic advances in cutaneous T-cell lymphoma","volume":"16","author":"Akilov","year":"2011","journal-title":"Skin Therapy Lett"},{"key":"B108","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/S0190-9622(89)70049-9","article-title":"Interferon alfa-2a in the treatment of cutaneous T cell lymphoma","volume":"20","author":"Olsen","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"B109","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1001\/archderm.138.8.1054","article-title":"Treatment of cutaneous T-cell lymphoma with combined immunomodulatory therapy: a 14-year experience at a single institution","volume":"138","author":"Suchin","year":"2002","journal-title":"Arch Dermatol"},{"key":"B110","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1080\/10428190410001693560","article-title":"Cutaneous T-cell lymphoma: a paradigm for biological therapies","volume":"45","author":"Pichardo","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"B111","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jdermsci.2016.05.004","article-title":"Tumor-associated M2 macrophages in mycosis fungoides acquire immunomodulatory function by interferon alpha and interferon gamma","volume":"83","author":"Furudate","year":"2016","journal-title":"J Dermatol Sci"},{"key":"B112","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1067\/mjd.2000.107808","article-title":"Immunomodulatory and pharmacologic properties of imiquimod","volume":"43","author":"Sauder","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"B113","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1001\/archderm.138.9.1137","article-title":"Treatment of stage IA cutaneous T-Cell lymphoma with topical application of the immune response modifier imiquimod","volume":"138","author":"Suchin","year":"2002","journal-title":"Arch Dermatol"},{"key":"B114","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1159\/000070962","article-title":"Imiquimod induces complete clearance of a PUVA-resistant plaque in mycosis fungoides","volume":"207","author":"Dummer","year":"2003","journal-title":"Dermatology"},{"key":"B115","first-page":"391","article-title":"Topical imiquimod as treatment for different kinds of cutaneous lymphoma","volume":"16","author":"Coors","year":"2006","journal-title":"Eur J Dermatol"},{"key":"B116","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.jdcr.2015.08.007","article-title":"Clearance of folliculotropic and tumor mycosis fungoides with topical 5% imiquimod","volume":"1","author":"Gordon","year":"2015","journal-title":"JAAD Case Rep"},{"key":"B117","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1182\/blood-2015-02-630335","article-title":"Topical resiquimod can induce disease regression and enhance T-cell effector functions in cutaneous T-cell lymphoma","volume":"126","author":"Rook","year":"2015","journal-title":"Blood"},{"key":"B118","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.4049\/jimmunol.174.3.1259","article-title":"Synthetic TLR agonists reveal functional differences between human TLR7 and TLR8","volume":"174","author":"Gorden","year":"2005","journal-title":"J Immunol"},{"key":"B119","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/35106079","article-title":"Histone deacetylases and cancer: causes and therapies","volume":"1","author":"Marks","year":"2001","journal-title":"Nat Rev Cancer"},{"key":"B120","doi-asserted-by":"publisher","first-page":"549","DOI":"10.4161\/cc.4.4.1564","article-title":"Histone deacetylase inhibitors in programmed cell death and cancer therapy","volume":"4","author":"Marks","year":"2005","journal-title":"Cell Cycle"},{"key":"B121","doi-asserted-by":"publisher","first-page":"3109","DOI":"10.1200\/JCO.2006.10.2434","article-title":"Phase IIb multicenter trial of vorinostat in patients with persistent, progressive, or treatment refractory cutaneous T-cell lymphoma","volume":"25","author":"Olsen","year":"2007","journal-title":"J Clin Oncol"},{"key":"B122","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1182\/blood-2006-06-025999","article-title":"Phase 2 trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) for refractory cutaneous T-cell lymphoma (CTCL)","volume":"109","author":"Duvic","year":"2007","journal-title":"Blood"},{"key":"B123","doi-asserted-by":"publisher","first-page":"5410","DOI":"10.1200\/JCO.2008.21.6150","article-title":"Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma","volume":"27","author":"Piekarz","year":"2009","journal-title":"J Clin Oncol"},{"key":"B124","doi-asserted-by":"publisher","first-page":"4485","DOI":"10.1200\/JCO.2010.28.9066","article-title":"Final results from a multicenter, international, pivotal study of romidepsin in refractory cutaneous T-cell lymphoma","volume":"28","author":"Whittaker","year":"2010","journal-title":"J Clin Oncol"},{"key":"B125","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1111\/j.1346-8138.2012.01554.x","article-title":"Phase I and pharmacokinetic study of the oral histone deacetylase inhibitor vorinostat in Japanese patients with relapsed or refractory cutaneous T-cell lymphoma","volume":"39","author":"Wada","year":"2012","journal-title":"J Dermatol"},{"key":"B126","doi-asserted-by":"publisher","first-page":"284","DOI":"10.3109\/10428194.2012.711829","article-title":"Clinically meaningful reduction in pruritus in patients with cutaneous T-cell lymphoma treated with romidepsin","volume":"54","author":"Kim","year":"2013","journal-title":"Leuk Lymphoma"},{"key":"B127","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clim.2015.02.014","article-title":"Improved pruritus correlates with lower levels of IL-31 in CTCL patients under different therapeutic modalities","volume":"158","author":"Cedeno-Laurent","year":"2015","journal-title":"Clin Immunol"},{"key":"B128","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1182\/blood-2003-01-0039","article-title":"cAC10-vcMMAE, an anti-CD30-monomethyl auristatin E conjugate with potent and selective antitumor activity","volume":"102","author":"Francisco","year":"2003","journal-title":"Blood"},{"key":"B129","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1200\/JCO.2011.38.0410","article-title":"Results of a pivotal phase II study of brentuximab vedotin for patients with relapsed or refractory Hodgkin\u2019s lymphoma","volume":"30","author":"Younes","year":"2012","journal-title":"J Clin Oncol"},{"key":"B130","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1634\/theoncologist.2012-0133","article-title":"Brentuximab vedotin in transplant-naive patients with relapsed or refractory Hodgkin lymphoma: analysis of two phase I studies","volume":"17","author":"Forero-Torres","year":"2012","journal-title":"Oncologist"},{"key":"B131","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/S0140-6736(17)31266-7","article-title":"Brentuximab vedotin or physician\u2019s choice in CD30-positive cutaneous T-cell lymphoma (ALCANZA): an international, open-label, randomised, phase 3, multicentre trial","volume":"390","author":"Prince","year":"2017","journal-title":"Lancet"},{"key":"B132","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1200\/JCO.2013.52.0924","article-title":"Multicenter phase II study of mogamulizumab (KW-0761), a defucosylated anti-cc chemokine receptor 4 antibody, in patients with relapsed peripheral T-cell lymphoma and cutaneous T-cell lymphoma","volume":"32","author":"Ogura","year":"2014","journal-title":"J Clin Oncol"},{"key":"B133","doi-asserted-by":"publisher","first-page":"1883","DOI":"10.1182\/blood-2014-09-600924","article-title":"Phase 1\/2 study of mogamulizumab, a defucosylated anti-CCR4 antibody, in previously treated patients with cutaneous T-cell lymphoma","volume":"125","author":"Duvic","year":"2015","journal-title":"Blood"},{"key":"B134","doi-asserted-by":"publisher","first-page":"e1022306","DOI":"10.1080\/2162402X.2015.1022306","article-title":"A novel targeted immunotherapy for CTCL is on its way: anti-KIR3DL2 mAb IPH4102 is potent and safe in non-clinical studies","volume":"4","author":"Sicard","year":"2015","journal-title":"Oncoimmunology"},{"key":"B135","doi-asserted-by":"publisher","first-page":"142","DOI":"10.4103\/ijd.IJD_73_17","article-title":"New targeted treatments for cutaneous T-cell Lymphomas","volume":"62","author":"Bagot","year":"2017","journal-title":"Indian J Dermatol"},{"key":"B136","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1182\/blood-2013-09-525915","article-title":"Results of an open-label multicenter phase 2 trial of lenalidomide monotherapy in refractory mycosis fungoides and Sezary syndrome","volume":"123","author":"Querfeld","year":"2014","journal-title":"Blood"},{"key":"B137","doi-asserted-by":"publisher","first-page":"4293","DOI":"10.1200\/JCO.2007.11.4207","article-title":"Phase II trial of proteasome inhibitor bortezomib in patients with relapsed or refractory cutaneous T-cell lymphoma","volume":"25","author":"Zinzani","year":"2007","journal-title":"J Clin Oncol"},{"key":"B138","doi-asserted-by":"publisher","first-page":"4024","DOI":"10.1182\/blood-2011-05-351346","article-title":"EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma","volume":"118","author":"Kempf","year":"2011","journal-title":"Blood"},{"key":"B139","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.1182\/blood.V96.12.3681","article-title":"CD30(+) anaplastic large cell lymphoma: a review of its histopathologic, genetic, and clinical features","volume":"96","author":"Stein","year":"2000","journal-title":"Blood"},{"key":"B140","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/S0037-1963(03)00138-0","article-title":"Systemic and primary cutaneous anaplastic large cell lymphomas","volume":"40","author":"Kadin","year":"2003","journal-title":"Semin Hematol"},{"key":"B141","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1002\/hon.897","article-title":"Anaplastic large cell lymphoma: one or more entities among T-cell lymphoma?","volume":"27","author":"Fornari","year":"2009","journal-title":"Hematol Oncol"},{"key":"B142","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/modpathol.2010.225","article-title":"Specificity of IRF4 translocations for primary cutaneous anaplastic large cell lymphoma: a multicenter study of 204 skin biopsies","volume":"24","author":"Wada","year":"2011","journal-title":"Mod Pathol"},{"key":"B143","doi-asserted-by":"crossref","first-page":"3653","DOI":"10.1182\/blood.V95.12.3653.012k23_3653_3661","article-title":"Primary and secondary cutaneous CD30(+) lymphoproliferative disorders: a report from the Dutch Cutaneous Lymphoma Group on the long-term follow-up data of 219 patients and guidelines for diagnosis and treatment","volume":"95","author":"Bekkenk","year":"2000","journal-title":"Blood"},{"key":"B144","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1111\/j.1346-8138.2010.01049.x","article-title":"Retrospective analysis of 133 patients with cutaneous lymphomas from a single Japanese medical center between 1995 and 2008","volume":"38","author":"Fujita","year":"2011","journal-title":"J Dermatol"},{"key":"B145","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1016\/j.jaad.2015.12.053","article-title":"Cutaneous anaplastic large-cell lymphoma (ALCL): A comparative clinical feature and survival outcome analysis of 52 cases according to primary tumor site","volume":"74","author":"Lee","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"B146","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1053\/j.semdp.2016.11.005","article-title":"A new era for cutaneous CD30-positive T-cell lymphoproliferative disorders","volume":"34","author":"Kempf","year":"2017","journal-title":"Semin Diagn Pathol"},{"key":"B147","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1046\/j.1365-2133.2003.05248.x","article-title":"Pyogenic lymphoma of the skin: a peculiar variant of primary cutaneous neutrophil-rich CD30+ anaplastic large-cell lymphoma. Clinicopathological study of four cases and review of the literature","volume":"148","author":"Burg","year":"2003","journal-title":"Br J Dermatol"},{"key":"B148","doi-asserted-by":"publisher","first-page":"1697","DOI":"10.3324\/haematol.2009.021428","article-title":"Disturbed expression of the T-cell receptor\/CD3 complex and associated signaling molecules in CD30+ T-cell lymphoproliferations","volume":"95","author":"Geissinger","year":"2010","journal-title":"Haematologica"},{"key":"B149","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1093\/annonc\/5.suppl_1.S25","article-title":"Primary Ki-1-positive anaplastic large-cell lymphoma: a distinct clinicopathologic entity","volume":"5","author":"Kadin","year":"1994","journal-title":"Ann Oncol"},{"key":"B150","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1001\/archderm.140.4.441","article-title":"Lymphomatoid papulosis: reappraisal of clinicopathologic presentation and classification into subtypes A, B, and C","volume":"140","author":"El Shabrawi-Caelen","year":"2004","journal-title":"Arch Dermatol"},{"key":"B151","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1097\/PAS.0b013e3181e75356","article-title":"A variant of lymphomatoid papulosis simulating primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma. Description of 9 cases","volume":"34","author":"Saggini","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"B152","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/PAS.0b013e3182648596","article-title":"Angioinvasive lymphomatoid papulosis: a new variant simulating aggressive lymphomas","volume":"37","author":"Kempf","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"B153","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1200\/JCO.1995.13.6.1343","article-title":"CD30\/Ki-1-positive lymphoproliferative disorders of the skin \u2013 clinicopathologic correlation and statistical analysis of 86 cases: a multicentric study from the European Organization for Research and Treatment of Cancer Cutaneous Lymphoma Project Group","volume":"13","author":"Paulli","year":"1995","journal-title":"J Clin Oncol"},{"key":"B154","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1067\/S0190-9622(03)01577-9","article-title":"Lymphomatoid papulosis associated with mycosis fungoides: a study of 21 patients including analyses for clonality","volume":"49","author":"Zackheim","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"B155","doi-asserted-by":"crossref","first-page":"4379","DOI":"10.1182\/blood.V122.21.4379.4379","article-title":"Response of rare variants of cutaneous T cell lymphoma (CTCL) to treatment with bexarotene. A prospective German DeCOG trial","volume":"122","author":"Weichenthal","year":"2013","journal-title":"Blood"},{"key":"B156","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1111\/bjh.13222","article-title":"A Phase II trial of Belinostat (PXD101) in patients with relapsed or refractory peripheral or cutaneous T-cell lymphoma","volume":"168","author":"Foss","year":"2015","journal-title":"Br J Haematol"},{"key":"B157","doi-asserted-by":"publisher","first-page":"449","DOI":"10.3324\/haematol.2009.015024","article-title":"Cutaneous presentation of ALK-positive anaplastic large cell lymphoma following insect bites: evidence for an association in five cases","volume":"95","author":"Lamant","year":"2010","journal-title":"Haematologica"},{"key":"B158","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1182\/blood.V99.5.1505","article-title":"Frequent expression of CCR4 in adult T-cell leukemia and human T-cell leukemia virus type 1-transformed T cells","volume":"99","author":"Yoshie","year":"2002","journal-title":"Blood"},{"key":"B159","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1111\/j.1365-2141.1991.tb08051.x","article-title":"Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia-lymphoma. A report from the Lymphoma Study Group (1984-87)","volume":"79","author":"Shimoyama","year":"1991","journal-title":"Br J Haematol"},{"key":"B160","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1111\/cas.13398","article-title":"Epidemiological and clinical features of adult T-cell leukemia-lymphoma in Japan, 2010-2011: a nationwide survey","volume":"108","author":"Nosaka","year":"2017","journal-title":"Cancer Sci"},{"key":"B161","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1080\/02841860802657235","article-title":"Adult T-cell leukemia\/lymphoma (ATL) presenting in the skin: clinical, histological and immunohistochemical features of 52 cases","volume":"48","author":"Bittencourt","year":"2009","journal-title":"Acta Oncol"},{"key":"B162","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1111\/j.1346-8138.1999.tb02093.x","article-title":"Clinicopathologic analysis of 124 cases of adult T-cell leukemia\/lymphoma with cutaneous manifestations: the smouldering type with skin manifestations has a poorer prognosis than previously thought","volume":"26","author":"Setoyama","year":"1999","journal-title":"J Dermatol"},{"key":"B163","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1111\/1346-8138.12374","article-title":"Meeting report on the possible proposal of an extranodal primary cutaneous variant in the lymphoma type of adult T-cell leukemia-lymphoma","volume":"41","author":"Tsukasaki","year":"2014","journal-title":"J Dermatol"},{"key":"B164","doi-asserted-by":"publisher","first-page":"3961","DOI":"10.1182\/blood-2010-11-316794","article-title":"Type of skin eruption is an independent prognostic indicator for adult T-cell leukemia\/lymphoma","volume":"117","author":"Sawada","year":"2011","journal-title":"Blood"},{"key":"B165","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1111\/1346-8138.12328","article-title":"Skin manifestations of adult T-cell leukemia\/lymphoma: clinical, cytological and immunological features","volume":"41","author":"Tokura","year":"2014","journal-title":"J Dermatol"},{"key":"B166","doi-asserted-by":"crossref","first-page":"3909","DOI":"10.1182\/blood.V91.10.3909","article-title":"Constitutive chemokine production results in activation of leukocyte function-associated antigen-1 on adult T-cell leukemia cells","volume":"91","author":"Tanaka","year":"1998","journal-title":"Blood"},{"key":"B167","first-page":"4939","article-title":"Human T-cell leukemia virus type I tax activates transcription of the human monocyte chemoattractant protein-1 gene through two nuclear factor-kappaB sites","volume":"60","author":"Mori","year":"2000","journal-title":"Cancer Res"},{"key":"B168","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1182\/blood.V98.4.1150","article-title":"Autocrine antiapoptotic stimulation of cultured adult T-cell leukemia cells by overexpression of the chemokine I-309","volume":"98","author":"Ruckes","year":"2001","journal-title":"Blood"},{"key":"B169","first-page":"3625","article-title":"Clinical significance of CCR4 expression in adult T-cell leukemia\/lymphoma: its close association with skin involvement and unfavorable outcome","volume":"9","author":"Ishida","year":"2003","journal-title":"Clin Cancer Res"},{"key":"B170","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1182\/blood.V95.1.30","article-title":"Increased chemokine receptor CCR7\/EBI1 expression enhances the infiltration of lymphoid organs by adult T-cell leukemia cells","volume":"95","author":"Hasegawa","year":"2000","journal-title":"Blood"},{"key":"B171","doi-asserted-by":"publisher","first-page":"2427","DOI":"10.1158\/1078-0432.CCR-04-0491","article-title":"Production of thymus and activation-regulated chemokine and macrophage-derived chemokine by CCR4+ adult T-cell leukemia cells","volume":"11","author":"Shimauchi","year":"2005","journal-title":"Clin Cancer Res"},{"key":"B172","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/j.1365-2141.2004.04999.x","article-title":"Expression of FoxP3, a key molecule in CD4CD25 regulatory T cells, in adult T-cell leukaemia\/lymphoma cells","volume":"126","author":"Karube","year":"2004","journal-title":"Br J Haematol"},{"key":"B173","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/j.1349-7006.2005.00080.x","article-title":"Possible origin of adult T-cell leukemia\/lymphoma cells from human T lymphotropic virus type-1-infected regulatory T cells","volume":"96","author":"Kohno","year":"2005","journal-title":"Cancer Sci"},{"key":"B174","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1111\/j.1349-7006.2007.00646.x","article-title":"Adult T-cell leukemia\/lymphoma cells from blood and skin tumors express cytotoxic T lymphocyte-associated antigen-4 and Foxp3 but lack suppressor activity toward autologous CD8+ T cells","volume":"99","author":"Shimauchi","year":"2008","journal-title":"Cancer Sci"},{"key":"B175","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jaci.2008.10.031","article-title":"IL-17 in atopic eczema: linking allergen-specific adaptive and microbial-triggered innate immune response","volume":"123","author":"Eyerich","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"B176","doi-asserted-by":"publisher","first-page":"3772","DOI":"10.1158\/1078-0432.CCR-12-0292","article-title":"Defective epidermal innate immunity and resultant superficial dermatophytosis in adult T-cell leukemia\/lymphoma","volume":"18","author":"Sawada","year":"2012","journal-title":"Clin Cancer Res"},{"key":"B177","doi-asserted-by":"publisher","first-page":"8504","DOI":"10.4049\/jimmunol.181.12.8504","article-title":"IL-17A enhances vitamin D3-induced expression of cathelicidin antimicrobial peptide in human keratinocytes","volume":"181","author":"Peric","year":"2008","journal-title":"J Immunol"},{"key":"B178","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.clim.2013.03.013","article-title":"Defective epidermal induction of S100A7\/psoriasin associated with low frequencies of skin-infiltrating Th17\u2009cells in dermatophytosis-prone adult T cell leukemia\/lymphoma","volume":"148","author":"Sawada","year":"2013","journal-title":"Clin Immunol"},{"key":"B179","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1111\/j.1365-4632.2008.03707.x","article-title":"Scabies superimposed on skin lesions of adult T-cell leukemia\/lymphoma: case report and literature review","volume":"47","author":"Kabashima","year":"2008","journal-title":"Int J Dermatol"},{"key":"B180","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/leu.2008.272","article-title":"PD-1\/PD-L1 expression in human T-cell leukemia virus type 1 carriers and adult T-cell leukemia\/lymphoma patients","volume":"23","author":"Kozako","year":"2009","journal-title":"Leukemia"},{"key":"B181","doi-asserted-by":"publisher","first-page":"2585","DOI":"10.1002\/ijc.23042","article-title":"Augmented expression of programmed death-1 in both neoplastic and non-neoplastic CD4+ T-cells in adult T-cell leukemia\/lymphoma","volume":"121","author":"Shimauchi","year":"2007","journal-title":"Int J Cancer"},{"key":"B182","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1038\/nature18294","article-title":"Aberrant PD-L1 expression through 3\u2019-UTR disruption in multiple cancers","volume":"534","author":"Kataoka","year":"2016","journal-title":"Nature"},{"key":"B183","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1200\/JCO.2011.37.3472","article-title":"Defucosylated anti-CCR4 monoclonal antibody (KW-0761) for relapsed adult T-cell leukemia-lymphoma: a multicenter phase II study","volume":"30","author":"Ishida","year":"2012","journal-title":"J Clin Oncol"},{"key":"B184","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1111\/bjh.14634","article-title":"Clinical significance of cutaneous adverse reaction to mogamulizumab in relapsed or refractory adult T-cell leukaemia-lymphoma","volume":"181","author":"Tokunaga","year":"2018","journal-title":"Br J Haematol"},{"key":"B185","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.2340\/00015555-2421","article-title":"Cutaneous adverse reaction to mogamulizumab may indicate favourable prognosis in adult T-cell leukaemia-lymphoma","volume":"96","author":"Yonekura","year":"2016","journal-title":"Acta Derm Venereol"},{"key":"B186","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1111\/cas.12116","article-title":"Stevens-Johnson syndrome associated with mogamulizumab treatment of adult T-cell leukemia\/lymphoma","volume":"104","author":"Ishida","year":"2013","journal-title":"Cancer Sci"},{"key":"B187","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1111\/1346-8138.12419","article-title":"Effect of anti-CCR4 monoclonal antibody (mogamulizumab) on adult T-cell leukemia-lymphoma: cutaneous adverse reactions may predict the prognosis","volume":"41","author":"Yonekura","year":"2014","journal-title":"J Dermatol"},{"key":"B188","doi-asserted-by":"publisher","first-page":"3426","DOI":"10.1200\/JCO.2016.67.8250","article-title":"Pretransplantation Anti-CCR4 antibody mogamulizumab against adult T-cell leukemia\/lymphoma is associated with significantly increased risks of severe and corticosteroid-refractory graft-versus-host disease, nonrelapse mortality, and overall mortality","volume":"34","author":"Fuji","year":"2016","journal-title":"J Clin Oncol"},{"key":"B189","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1016\/j.bbmt.2016.05.017","article-title":"Mogamulizumab treatment prior to allogeneic hematopoietic stem cell transplantation induces severe acute graft-versus-host disease","volume":"22","author":"Sugio","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"key":"B190","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1097\/00000478-199807000-00010","article-title":"Subcutaneous panniculitis-like T-cell lymphoma: clinicopathologic, immunophenotypic, and genotypic analysis of alpha\/beta and gamma\/delta subtypes","volume":"22","author":"Salhany","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"B191","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1097\/01.pas.0000126719.71954.4f","article-title":"Subcutaneous, blastic natural killer (NK), NK\/T-cell, and other cytotoxic lymphomas of the skin: a morphologic, immunophenotypic, and molecular study of 50 patients","volume":"28","author":"Massone","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"B192","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1097\/PAS.0000000000000596","article-title":"Useful parameters for distinguishing subcutaneous panniculitis-like T-cell lymphoma from lupus erythematosus panniculitis","volume":"40","author":"LeBlanc","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"B193","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1053\/j.semdp.2016.11.009","article-title":"Cutaneous lymphomas with a panniculitic presentation","volume":"34","author":"Willemze","year":"2017","journal-title":"Semin Diagn Pathol"},{"key":"B194","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1182\/blood-2007-04-087288","article-title":"Subcutaneous panniculitis-like T-cell lymphoma: definition, classification, and prognostic factors: an EORTC Cutaneous Lymphoma Group Study of 83 cases","volume":"111","author":"Willemze","year":"2008","journal-title":"Blood"},{"key":"B195","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1111\/j.0303-6987.2005.00351.x","article-title":"Lupus erythematosus panniculitis (lupus profundus): clinical, histopathological, and molecular analysis of nine cases","volume":"32","author":"Massone","year":"2005","journal-title":"J Cutan Pathol"},{"key":"B196","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1111\/his.12105","article-title":"The presence of clusters of plasmacytoid dendritic cells is a helpful feature for differentiating lupus panniculitis from subcutaneous panniculitis-like T-cell lymphoma","volume":"62","author":"Liau","year":"2013","journal-title":"Histopathology"},{"key":"B197","doi-asserted-by":"publisher","first-page":"1413","DOI":"10.1111\/jdv.13258","article-title":"CCR5 and CXCR3 expression in a case of subcutaneous panniculitis-like T-cell lymphoma","volume":"30","author":"Honda","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"B198","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1684\/ejd.2017.3016","article-title":"CCR4 and CCR5 expression in a case of subcutaneous panniculitis-like T-cell lymphoma","volume":"27","author":"Kitayama","year":"2017","journal-title":"Eur J Dermatol"},{"key":"B199","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1111\/bjd.13053","article-title":"Systemic corticosteroids for subcutaneous panniculitis-like T-cell lymphoma","volume":"171","author":"Guenova","year":"2014","journal-title":"Br J Dermatol"},{"key":"B200","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1080\/10428190601078456","article-title":"Cyclosporin in subcutaneous panniculitis-like T-cell lymphoma","volume":"48","author":"Rojnuckarin","year":"2007","journal-title":"Leuk Lymphoma"},{"key":"B201","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1159\/000323565","article-title":"Cyclosporine A for chemotherapy-resistant subcutaneous panniculitis-like T cell lymphoma with hemophagocytic syndrome","volume":"126","author":"Mizutani","year":"2011","journal-title":"Acta Haematol"},{"key":"B202","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.clml.2011.06.016","article-title":"Bexarotene is active against subcutaneous panniculitis-like T-cell lymphoma in adult and pediatric populations","volume":"12","author":"Mehta","year":"2012","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"B203","doi-asserted-by":"publisher","first-page":"3407","DOI":"10.1182\/blood-2002-05-1597","article-title":"Gamma-delta T-cell phenotype is associated with significantly decreased survival in cutaneous T-cell lymphoma","volume":"101","author":"Toro","year":"2003","journal-title":"Blood"},{"key":"B204","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.1097\/PAS.0b013e31826a5038","article-title":"Cutaneous gammadelta T-cell lymphomas: a spectrum of presentations with overlap with other cytotoxic lymphomas","volume":"36","author":"Guitart","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"B205","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/S1525-1578(10)60610-1","article-title":"Hepatosplenic and subcutaneous panniculitis-like gamma\/delta T cell lymphomas are derived from different Vdelta subsets of gamma\/delta T lymphocytes","volume":"2","author":"Przybylski","year":"2000","journal-title":"J Mol Diagn"},{"key":"B206","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1038\/nrclinonc.2009.169","article-title":"Gamma-delta T-cell lymphomas","volume":"6","author":"Tripodo","year":"2009","journal-title":"Nat Rev Clin Oncol"},{"key":"B207","first-page":"1723","article-title":"Nonhepatosplenic gammadelta T-cell lymphoma: a subset of cytotoxic lymphomas with mucosal or skin localization","volume":"91","author":"Arnulf","year":"1998","journal-title":"Blood"},{"key":"B208","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1001\/archderm.136.8.1024","article-title":"Gamma delta T-cell lymphoma of the skin: a clinical, microscopic, and molecular study","volume":"136","author":"Toro","year":"2000","journal-title":"Arch Dermatol"},{"key":"B209","doi-asserted-by":"publisher","first-page":"653","DOI":"10.2340\/00015555-0728","article-title":"Cutaneous gamma\/delta T-cell lymphoma during treatment with etanercept for rheumatoid arthritis","volume":"89","author":"Koens","year":"2009","journal-title":"Acta Derm Venereol"},{"key":"B210","doi-asserted-by":"publisher","first-page":"S121","DOI":"10.1016\/j.jaad.2004.05.042","article-title":"High-dose chemotherapy with autologous blood stem cell transplantation for aggressive subcutaneous panniculitis-like T-cell lymphoma","volume":"52","author":"Alaibac","year":"2005","journal-title":"J Am Acad Dermatol"},{"key":"B211","doi-asserted-by":"publisher","first-page":"1010.e","DOI":"10.1016\/j.jaad.2015.01.003","article-title":"Hematopoietic stem cell transplantation for primary cutaneous gammadelta T-cell lymphoma and refractory subcutaneous panniculitis-like T-cell lymphoma","volume":"72","author":"Gibson","year":"2015","journal-title":"J Am Acad Dermatol"},{"key":"B212","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1097\/DAD.0b013e31819f19bb","article-title":"Primary cutaneous CD4+ small-\/medium-sized pleomorphic T-cell lymphoma: a cutaneous nodular proliferation of pleomorphic T lymphocytes of undetermined significance? A study of 136 cases","volume":"31","author":"Beltraminelli","year":"2009","journal-title":"Am J Dermatopathol"},{"key":"B213","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.jaad.2010.07.028","article-title":"Reappraisal of the provisional entity primary cutaneous CD4+ small\/medium pleomorphic T-cell lymphoma: a series of 10 adult and pediatric patients and review of the literature","volume":"65","author":"Baum","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"B214","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/modpathol.2008.40","article-title":"Primary cutaneous CD4-positive small\/medium-sized pleomorphic T-cell lymphoma: a clonal T-cell lymphoproliferative disorder with indolent behavior","volume":"21","author":"Grogg","year":"2008","journal-title":"Mod Pathol"},{"key":"B215","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1097\/PAS.0b013e31818e52fe","article-title":"Primary cutaneous CD4+ small\/medium-sized pleomorphic T-cell lymphoma expresses follicular T-cell markers","volume":"33","author":"Rodriguez Pinilla","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"B216","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1097\/PAS.0b013e318230df87","article-title":"Expression of programmed death-1 in primary cutaneous CD4-positive small\/medium-sized pleomorphic T-cell lymphoma, cutaneous pseudo-T-cell lymphoma, and other types of cutaneous T-cell lymphoma","volume":"36","author":"Cetinozman","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"B217","first-page":"187","article-title":"Cutaneous pseudolymphomas: classification and differential diagnosis","volume":"13","author":"Rijlaarsdam","year":"1994","journal-title":"Semin Dermatol"},{"key":"B218","first-page":"1941","article-title":"Immunophenotyping and gene rearrangement analysis provide additional criteria to differentiate between cutaneous T-cell lymphomas and pseudo-T-cell lymphomas","volume":"150","author":"Bakels","year":"1997","journal-title":"Am J Pathol"},{"key":"B219","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1097\/DAD.0000000000000597","article-title":"Differential NFATc1 expression in primary cutaneous CD4+ small\/medium-sized pleomorphic T-cell lymphoma and other forms of cutaneous T-cell lymphoma and pseudolymphoma","volume":"39","author":"Magro","year":"2017","journal-title":"Am J Dermatopathol"},{"key":"B220","doi-asserted-by":"publisher","first-page":"3364","DOI":"10.1200\/JCO.2008.16.1307","article-title":"Primary cutaneous small\/medium CD4+ T-cell lymphomas: a heterogeneous group of tumors with different clinicopathologic features and outcome","volume":"26","author":"Garcia-Herrera","year":"2008","journal-title":"J Clin Oncol"},{"key":"B221","doi-asserted-by":"publisher","first-page":"389","DOI":"10.2165\/11590390-000000000-00000","article-title":"Primary cutaneous small- to medium-sized CD4+ pleomorphic T-cell lymphoma: a retrospective case series and review of the provisional cutaneous lymphoma category","volume":"12","author":"Williams","year":"2011","journal-title":"Am J Clin Dermatol"},{"key":"B222","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1001\/archderm.118.8.588","article-title":"Hydroa vacciniforme: diagnosis and therapy","volume":"118","author":"Goldgeier","year":"1982","journal-title":"Arch Dermatol"},{"key":"B223","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1001\/archderm.122.11.1306","article-title":"Coexistence of hydroa vacciniforme and malignant lymphoma","volume":"122","author":"Oono","year":"1986","journal-title":"Arch Dermatol"},{"key":"B224","doi-asserted-by":"publisher","first-page":"3101","DOI":"10.1182\/blood-2013-05-502203","article-title":"Hydroa vacciniforme-like lymphoma: a chronic EBV+ lymphoproliferative disorder with risk to develop a systemic lymphoma","volume":"122","author":"Quintanilla-Martinez","year":"2013","journal-title":"Blood"},{"key":"B225","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1046\/j.1365-2230.2001.00805.x","article-title":"Epstein-Barr virus-associated peripheral T-cell lymphoma in adults with hydroa vacciniforme-like lesions","volume":"26","author":"Cho","year":"2001","journal-title":"Clin Exp Dermatol"},{"key":"B226","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1016\/S0190-9622(98)70120-3","article-title":"Angiocentric cutaneous T-cell lymphoma of childhood (hydroa-like lymphoma): a distinctive type of cutaneous T-cell lymphoma","volume":"38","author":"Magana","year":"1998","journal-title":"J Am Acad Dermatol"},{"key":"B227","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1046\/j.1365-2133.1999.02777.x","article-title":"The association of latent Epstein-Barr virus infection with hydroa vacciniforme","volume":"140","author":"Iwatsuki","year":"1999","journal-title":"Br J Dermatol"},{"key":"B228","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/00129039-200203000-00002","article-title":"Hydroa-like cutaneous T-cell lymphoma: a clinicopathologic and molecular genetic study of 16 pediatric cases from Peru","volume":"10","author":"Barrionuevo","year":"2002","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"B229","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.1182\/blood.V98.10.3173","article-title":"Mosquito allergy and Epstein-Barr virus-associated T\/natural killer-cell lymphoproliferative disease","volume":"98","author":"Kawa","year":"2001","journal-title":"Blood"},{"key":"B230","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1001\/archderm.142.5.587","article-title":"Pathogenic link between hydroa vacciniforme and Epstein-Barr virus-associated hematologic disorders","volume":"142","author":"Iwatsuki","year":"2006","journal-title":"Arch Dermatol"},{"key":"B231","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1111\/j.1365-4632.2007.03102.x","article-title":"Hydroa vacciniforme-like Epstein-Barr virus-associated monoclonal T-lymphoproliferative disorder in a child","volume":"46","author":"Wu","year":"2007","journal-title":"Int J Dermatol"},{"key":"B232","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1001\/archderm.126.3.362","article-title":"Severe hypersensitivity to mosquito bites associated with natural killer cell lymphocytosis","volume":"126","author":"Tokura","year":"1990","journal-title":"Arch Dermatol"},{"key":"B233","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1182\/blood-2011-10-381921","article-title":"EBV-associated T\/NK-cell lymphoproliferative diseases in nonimmunocompromised hosts: prospective analysis of 108 cases","volume":"119","author":"Kimura","year":"2012","journal-title":"Blood"},{"key":"B234","first-page":"355","article-title":"EBV-positive T-cell and NK-cell lymphoproliferative diseases of childhood","volume-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","author":"Quintanilla-Martinez","year":"2017"},{"key":"B235","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1097\/DAD.0b013e31825c3a33","article-title":"Primary cutaneous CD8(+) small- to medium-sized lymphoproliferative disorder in extrafacial sites: clinicopathologic features and concept on their classification","volume":"35","author":"Kempf","year":"2013","journal-title":"Am J Dermatopathol"},{"key":"B236","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1111\/cup.12045","article-title":"Indolent CD8(+) lymphoid proliferation of acral sites: a clinicopathologic study of six patients with some atypical features","volume":"40","author":"Greenblatt","year":"2013","journal-title":"J Cutan Pathol"},{"key":"B237","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.5858\/arpa.2017-0230-RA","article-title":"Primary cutaneous acral CD8(+) T-cell lymphoma","volume":"141","author":"Hathuc","year":"2017","journal-title":"Arch Pathol Lab Med"},{"key":"B238","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1111\/cup.12633","article-title":"Indolent CD8-positive lymphoid proliferation of acral sites: three further cases of a rare entity and an update on a unique patient","volume":"43","author":"Kluk","year":"2016","journal-title":"J Cutan Pathol"},{"key":"B239","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/S0002-9440(10)65144-9","article-title":"Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior","volume":"155","author":"Berti","year":"1999","journal-title":"Am J Pathol"},{"key":"B240","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.jaad.2011.07.043","article-title":"Primary cutaneous aggressive epidermotropic CD8+ T-cell lymphoma: proposed diagnostic criteria and therapeutic evaluation","volume":"67","author":"Nofal","year":"2012","journal-title":"J Am Acad Dermatol"},{"key":"B241","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1111\/his.12371","article-title":"Aggressive epidermotropic cutaneous CD8+ lymphoma: a cutaneous lymphoma with distinct clinical and pathological features. Report of an EORTC cutaneous lymphoma task force workshop","volume":"67","author":"Robson","year":"2015","journal-title":"Histopathology"},{"key":"B242","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/modpathol.2016.240","article-title":"Primary cutaneous aggressive epidermotropic cytotoxic T-cell lymphomas: reappraisal of a provisional entity in the 2016 WHO classification of cutaneous lymphomas","volume":"30","author":"Guitart","year":"2017","journal-title":"Mod Pathol"},{"key":"B243","doi-asserted-by":"publisher","first-page":"2496","DOI":"10.1056\/NEJMcpc0706687","article-title":"Case records of the Massachusetts general hospital. Case 38-2007. A 44-year-old woman with generalized, painful, ulcerated skin lesions","volume":"357","author":"Liu","year":"2007","journal-title":"N Engl J Med"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2018.00198\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,2]],"date-time":"2023-09-02T19:34:06Z","timestamp":1693683246000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fonc.2018.00198\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,4]]},"references-count":243,"alternative-id":["10.3389\/fonc.2018.00198"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2018.00198","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.733477717.793573953","asserted-by":"object"}]},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,4]]},"article-number":"198"}}